An observational study in Brain Infarction, sponsored by Munich Municipal Hospital. Status unknown at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-02-17.
Sponsored by Munich Municipal Hospital · Observational
The aim of this study is to compare time delay and safety parameters of stroke patients initially admitted to a rural primary stroke center (PSC) who receive endovascular treatment (EVT) by a Flying Intervention Team with patients who receive EVT after secondary transfer to a comprehensive stroke center (CSC).
A novel health care concept was implemented in the telemedical stroke network TEMPiS (Telemedical Project for integrative Stroke Care) to reduce time delays to EVT in stroke patients with large vessel occlusion: After telemedicine-assisted identification of EVT candidates in a PSC, a Flying Intervention Team (neuroradiologist and angiography assistant) is flown from a CSC via helicopter to the PSC to perform EVT in the local angiography suite. Flying Intervention Team service runs from 8 a.m. to 10 p.m. Patients remain at local stroke unit for further treatment.
Analysis will include time delay to EVT, recanalization, symptomatic intracerebral hemorrhage, periprocedural complications, in-hospital complications, and mortality.
93 studies on the registry are indexed under Brain Infarction; 19 are open to participants now.
This study's enrollment of 477 is close to the median of 477 across 23 observational studies indexed under Brain Infarction.
Browse Brain Infarction studies →Munich Municipal Hospital is the lead sponsor of 7 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Acute stroke patients eligible for endovascular treatment initially admitted to participating primary stroke center
Inclusion criteria:
Inclusion criteria for primary study population:
Exclusion criteria for primary study population:
Patients with ischemic stroke and large vessel occlusion admitted to a primary stroke center, for whom a Flying Intervention Team is flown to the primary stroke center in order to perform endovascular treatment.
Other: Endovascular treatment by Flying Intervention Team
Patients with ischemic stroke and large vessel occlusion admitted to a primary stroke center, who are transferred to a comprehensive stroke center for endovascular treatment.
After telemedicine-assisted decision for endovascular treatment, the Flying Intervention Team is transferred via helicopter to the primary stroke center and performs endovascular treatment in the local angiography suite.
Time from decision for endovascular treatment to groin puncture
Time from telemedicine-assisted decision for endovascular treatment to initiation of endovascular treatment by groin puncture
Time frame: day 1
Time from symptom onset to recanalization
Time from symptom onset to recanalization of previously occluded target artery by endovascular treatment
Time frame: day 1
Other procedural times of hyperacute care
Other procedural times between symptom onset, admission to PSC, first imaging, decision for endovascular treatment, initiation of endovascular treatment and completion of endovascular treatment
Time frame: day 1
Recanalization
Proportion of patients with antegrade reperfusion of more than half of the previously occluded target artery ischemic territory after endovascular treatment
Time frame: day 1
Symptomatic intracerebral hemorrhage
Proportion of patients with symptomatic intracerebral hemorrhage
Time frame: 7 days
In-hospital death or palliative care
In-hospital death or decision for palliative care
Time frame: 7 days
Periprocedural complications
Proportion of patients with periprocedural, endovascular treatment associated complications
Time frame: day 1
In-hospital complications
Proportion of patients with other in-hospital complications
Time frame: 7 days
Plan to share: No
Ran from Feb 2018 to primary completion in Oct 2019, 20 months.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Munich Municipal Hospital